Captrust Financial Advisors Sells 190 Shares of Balchem Co. (NASDAQ:BCPC)

Captrust Financial Advisors decreased its holdings in shares of Balchem Co. (NASDAQ:BCPC) by 5.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,558 shares of the basic materials company’s stock after selling 190 shares during the period. Captrust Financial Advisors’ holdings in Balchem were worth $626,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. nVerses Capital LLC bought a new stake in Balchem during the third quarter valued at $35,000. GAMMA Investing LLC lifted its stake in Balchem by 73.4% during the third quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company’s stock worth $148,000 after purchasing an additional 356 shares during the last quarter. Blue Trust Inc. lifted its stake in Balchem by 642.5% during the third quarter. Blue Trust Inc. now owns 839 shares of the basic materials company’s stock worth $148,000 after purchasing an additional 726 shares during the last quarter. TD Asset Management Inc bought a new stake in Balchem during the second quarter worth about $200,000. Finally, Heritage Family Offices LLP bought a new stake in Balchem during the second quarter worth about $206,000. Institutional investors own 87.91% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on BCPC. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright lifted their price target on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, November 4th.

Balchem Stock Up 1.6 %

BCPC opened at $178.21 on Thursday. The company has a market cap of $5.79 billion, a P/E ratio of 47.91, a P/E/G ratio of 5.30 and a beta of 0.67. The business’s 50-day moving average price is $174.93 and its 200-day moving average price is $168.79. The company has a current ratio of 2.98, a quick ratio of 1.90 and a debt-to-equity ratio of 0.21. Balchem Co. has a 12 month low of $133.82 and a 12 month high of $186.03.

Balchem Increases Dividend

The business also recently disclosed an annual dividend, which will be paid on Friday, January 17th. Stockholders of record on Thursday, December 26th will be issued a $0.87 dividend. The ex-dividend date of this dividend is Thursday, December 26th. This represents a dividend yield of 0.4%. This is an increase from Balchem’s previous annual dividend of $0.79. Balchem’s payout ratio is currently 10.75%.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.